Hospital
Starr County Hospital District
Starr County Hospital District was paid $6.72M by Medicaid between Jan 2019 and Nov 2024, across 103 billing codes. Its largest line is 99284, emergency room visit (serious) — 38% of everything it billed.
33Billing provider infoSTARR COUNTY HOSPITAL DISTRICT
RIO GRANDE CITY, TX 78582
RIO GRANDE CITY, TX 78582
33aNPI1760567085assigned 10/26/2006
33bProvider typeRural Acute Care Hospital
28Total paid$6.72M
24GClaims124,603
24DCodes billed103
24AFirst – last monthJan 2019 – Nov 2024
Compared with peers
Next to other Rural Acute Care Hospital providers in Texas
Rank by total paid#1 of 11
Median peer was paid$1.32M
This provider vs. median5.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 3,818 | $97K | |
| 2020 | 4,748 | $273K | |
| 2021 | 28,836 | $1.49M | |
| 2022 | 38,644 | $2.04M | |
| 2023 | 32,199 | $1.89M | |
| 2024incomplete | 16,358 | $926K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 38% | 4,769 | 4,558 | $2.52M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 4,349 | 4,236 | $1.24M |
| A0427 | Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 8.9% | 4,203 | 3,306 | $599K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.8% | 950 | 914 | $459K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 5.2% | 1,109 | 1,062 | $349K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.3% | 2,685 | 1,987 | $219K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.8% | 4,503 | 4,276 | $187K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.3% | 7,663 | 5,442 | $155K |
| 71045 | Radiologic examination, chest; single view | 2.0% | 2,822 | 2,695 | $136K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 5,109 | 2,511 | $86K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.2% | 328 | 327 | $80K |
| 80053 | Comprehensive metabolic panel | 1.0% | 10,266 | 9,321 | $69K |
91 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,006 | $58K |
| 85027 | <1% | 11,836 | $53K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,047 | $49K |
| 86328 | <1% | 518 | $48K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 942 | $36K |
| 87260 | <1% | 1,959 | $28K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 374 | $21K |
| 87430 | <1% | 1,212 | $21K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 522 | $17K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 657 | $16K |
| 81001 | <1% | 6,971 | $16K | |
| 96367 | <1% | 348 | $14K | |
| 74018 | <1% | 149 | $14K | |
| 87040 | <1% | 2,124 | $13K | |
| CP008 | <1% | 355 | $13K | |
| 84145 | <1% | 1,197 | $11K | |
| A0425 | Ground mileage, per statute mile | <1% | 5,102 | $11K |
| 83880 | <1% | 1,680 | $10K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 73 | $10K |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 237 | $10K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 808 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,710 | $9K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 69 | $9K |
| 80050 | General health panel | <1% | 113 | $8K |
| 83605 | <1% | 1,405 | $8K | |
| 80061 | Lipid panel | <1% | 1,520 | $7K |
| 83690 | <1% | 1,294 | $6K | |
| 87420 | <1% | 328 | $5K | |
| 84484 | <1% | 2,400 | $5K | |
| 83874 | <1% | 2,437 | $5K | |
| 82150 | <1% | 1,193 | $5K | |
| 80320 | <1% | 340 | $5K | |
| 82553 | <1% | 2,493 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,540 | $4K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 54 | $4K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 945 | $4K |
| 82550 | <1% | 1,829 | $4K | |
| 87070 | <1% | 400 | $3K | |
| 83525 | <1% | 189 | $3K | |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 12 | $3K |
| 72100 | <1% | 74 | $3K | |
| 85007 | <1% | 1,150 | $3K | |
| A0429 | Emergency ambulance ride, basic life support | <1% | 19 | $3K |
| 84703 | <1% | 286 | $2K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 12 | $2K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 13 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 134 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,112 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 238 | $2K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 74 | $2K |
| 84439 | <1% | 198 | $2K | |
| 86140 | <1% | 290 | $1K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 74 | $1K |
| 73562 | <1% | 28 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 922 | $1K |
| 83735 | <1% | 1,087 | $1K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 27 | $1K |
| 76770 | <1% | 38 | $1K | |
| 77080 | <1% | 178 | $972.34 | |
| 85730 | <1% | 571 | $513.14 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 76 | $508.28 |
| CP007 | <1% | 16 | $440.85 | |
| 85610 | <1% | 675 | $412.67 | |
| 82803 | <1% | 52 | $321.16 | |
| 72170 | <1% | 26 | $302.00 | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 37 | $285.56 |
| 85651 | <1% | 133 | $263.68 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 13 | $238.50 |
| 84480 | <1% | 12 | $228.72 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 27 | $134.38 |
| 82948 | <1% | 183 | $128.73 | |
| 84479 | <1% | 15 | $123.48 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 103 | $118.87 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 25 | $105.40 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 15 | $105.17 |
| 84100 | <1% | 131 | $93.75 | |
| 82570 | <1% | 479 | $90.99 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 28 | $80.80 |
| 86592 | <1% | 12 | $60.27 | |
| 82607 | <1% | 45 | $57.98 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 12 | $47.70 |
| 86901 | <1% | 14 | $31.14 | |
| 86900 | <1% | 14 | $31.14 | |
| 83540 | <1% | 28 | $21.76 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,595 | $14.00 |
| 84550 | <1% | 49 | $13.79 | |
| 82270 | <1% | 12 | $12.24 | |
| J2704 | Injection, propofol, 10 mg | 0% | 58 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 23 | $0.00 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 12 | $0.00 |
| 87631 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMUNOZ, THALIA (ADMINISTRATOR)
| Provider | Location | Paid |
|---|---|---|
| Starr County Hospital District | Roma, TX | $1.42M |
| Starr County Memorial Hospital | Rio Grande City, TX | $1.18M |
| Starr County Hospital District | Rio Grande City, TX | $474K |
| Starr County Hospital District | Rio Grande City, TX | $348.64 |
| Starr County Hospital District | Weslaco, TX | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.